Viability of endoscopic and excisional treatment of early rectal carcinoids

Anders Merg, Debrah Wirtzfeld, Jiping Wang, Richard Cheney, Kelli Bullard Dunn, Ashwani Rajput

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


With the advent of endoscopy, the incidence of rectal carcinoid tumors has not only risen, but the majority are localized at presentation. This has led to excisional and/or ablative therapy in lieu of radical resections. A single institute's experience with rectal carcinoids was reviewed to determine the impact this approach has had on outcomes, and evaluate any selection criteria for optimizing patient survival. A single institute's tumor registry was retrospectively queried, identifying 14 patients with rectal carcinoid tumors over a 28-year period. The mean age at diagnosis was 52.1∈±∈14. 4 years. Six of the 14 patients were female. Presenting symptoms included a change in bowel habits in six (38%), rectal bleeding in six (38%), and abdominal pain or distention in five (31%) patients. No patient had symptoms consistent with carcinoid syndrome. The rectal carcinoids were a mean 9. 2∈±∈3.4 cm from the anal verge and a mean 9∈±∈ 6 mm in size. Endoscopic and/or transanal excision/fulguration techniques treated 11 (79%) patients, whereas two (14%) patients underwent a low anterior resection (LAR). Surveillance entailed periodic endoscopy for a median 65 months (range 8-281). No patient developed recurrent carcinoid disease for a 20-year overall survival of 70%.

Original languageEnglish (US)
Pages (from-to)893-897
Number of pages5
JournalJournal of Gastrointestinal Surgery
Issue number7
StatePublished - Jul 2007
Externally publishedYes


  • Carcinoid tumors
  • Rectum
  • Treatment

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology


Dive into the research topics of 'Viability of endoscopic and excisional treatment of early rectal carcinoids'. Together they form a unique fingerprint.

Cite this